BiosimilarsAuthor :
Hardback
Published : Wednesday 21 November 2012
Description
However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the "generic rule" valid for small chemical entities. In response, a dedicated regulation was issued in the European Union.
You may also like ...
by
Hardback
21 Nov 2012
Medical equipment and techniques
€128.69
Extended stock – Dispatch 5-7 days
by
Hardback
09 Jul 2024
Individual architects and architectural firms
€58.50
by
Hardback
19 Sep 2023
Architecture
€56.16
Extended stock – Dispatch 5-7 days
by
Paperback
24 Nov 2022
Comparative religion
€26.33
Extended stock – Dispatch 5-7 days
Reviews